Stock Of The Day ......(Public, NASDAQ:GENZ) (Public, NYSE:RT)

1. Ruby Tuesday, Inc. (Public, NYSE:RT) Ruby Tuesday, Inc. (RTI) develops, operates and franchises casual dining restaurants in the United States, Puerto Rico, Guam, and 13 other countries and regions under the Ruby Tuesday brand. The Company also owns and operates two Wok Hay restaurants. At June 2, 2009, it owned and operated 672 Ruby Tuesday restaurants primarily in the Northeast, Southeast, Mid-Atlantic and Midwest of the United States. As of June 2, 2009, there were 229 domestic and international franchise restaurants located in 27 states primarily outside the Company’s existing markets primarily the Western United States and portions of the Midwest and Northeast and in the Asia Pacific Region, India, Middle East, Puerto Rico, Guam, Canada, Iceland, Eastern Europe, and Central and South America. On March 18, 2009, the Company acquired a Ruby Tuesday restaurant in Rockwall, Texas from a traditional domestic franchise.Ruby Tuesday, a restaurant chain, has reported a net income of $20.97 million, or $0.33 per diluted share, for the fourth quarter ended June 1, 2010, compared to $14.45 million, or $0.28 per diluted share, for the fourth quarter ended June 2, 2009.


Total revenue for the fourth quarter of fiscal 2010 was $313.45 million, compared to $317.25 million for the fourth quarter of fiscal 2009.

Net income for year ended June 1, 2010 was $45.34 million, or $0.73 per diluted share, compared to a net loss of $17.92 million, or $0.35 per diluted share, for the year ended June 2, 2009. Total revenue for fiscal 2010 was $1.19 billion, compared to $1.25 billion for fiscal 2009.


Sandy Beall, founder and CEO of Ruby Tuesday, said: "Fiscal 2010 presented a number of economic challenges. I am very proud of the way our team members responded to these challenges and enabled us to create positive momentum throughout our business. We have remained focused on our mission to be the best in the bar and grill segment by delivering a high quality casual dining experience with compelling value to every guest." RT has been on my buy list when it was at 1.30 a share ...


2. Genzyme Corporation (Public, NASDAQ:GENZ)
The company is rumored to be the best suitor for Sanofi-Aventis, which has reportedly been in the market for a large acquisition. Sanofi reportedly reached out to Genzyme about two weeks ago, but is awaiting an answer, according to DealBook.
Genzyme Corporation (Genzyme) is a biotechnology company. The Company’s product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease. Genzyme operates in four business segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases, including a family of diseases known as lysosomal storage disorders (LSDs). Cardiometabolic and Renal segment develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure and endocrine and cardiovascular diseases. Biosurgery develops, manufactures and distributes biotherapeutics and biomaterial-based products. Hematologic Oncology develops, manufactures and distributes products for the treatment of cancer.


Thoughts ?